drugset / Trial / NCT04324294

Contrast Enhanced Endoscopic Ultrasound in Pancreas Lesions

NCT04324294

Phase 1 Unknown 200 enrolled Cedars-Sinai Medical Center
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to determine whether quantitative contrast-enhanced endoscopic ultrasound (CE-EUS) improves the evaluation of pancreas tumors and precursor lesions, including cysts, compared to conventional endoscopic ultrasound.

Timeline

Start
2020-02-26
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent Intravenous